Impact of clopidogrel in coronary artery bypass grafting1 | Zendy

Lars Englberger | Zendy; B FAEH | Zendy; Pascal Berdat | Zendy; Franz R. Eberli | Zendy; B Meier | Zendy; T CARREL | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of clopidogrel in coronary artery bypass grafting1

Author(s) -

Lars Englberger,

B FAEH,

Pascal Berdat,

Franz R. Eberli,

B Meier,

T CARREL

Publication year - 2004

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2004.03.030

Subject(s) - clopidogrel , medicine , cardiogenic shock , aspirin , thienopyridine , anesthesia , cardiology , hemostasis , angina , surgery , myocardial infarction

Clopidogrel has become the standard of care to prevent thrombotic complications following cardiological interventions, in particular intracoronary stenting. In addition, patients with aspirin intolerance and those with carotid and peripheral vascular disease are also increasingly treated with clopidogrel. Platelet inhibition may become a concern for hemostasis in patients treated with clopidogrel who need emergency and undelayed surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research